PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|December 2, 2001
- Pharmaceutical Technology-12-02-2001
- Volume 25
- Issue 12
International Employment Survey 2001
Author(s)Maribel Rios
According to this year's survey, pharmaceutical employees working in Europe and in the united States are committing more hours to the job, earning higher salaries, and enjoying positive attitudes toward their current employment and outlooks for the future.
Advertisement
Articles in this issue
almost 25 years ago
Bioterrorism Threat Shines Spotlight on Drug Manufacturingalmost 25 years ago
E-Sourcing: Internet Facilitates Flexible Collaborationalmost 25 years ago
Outsourcing Outlookalmost 25 years ago
A Comprehensive Approach to Pharmaceutical Engineering TrainingAdvertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement